LEADER 01215nam--2200397---450-
001 990006059100203316
005 20150715115954.0
010   $a2-88250-023-8
035   $a000605910
035   $aUSA01000605910
035   $a(ALEPH)000605910USA01
035   $a000605910
100   $a20150715d1991----km-y0itay50------ba
101   $afre
102   $aCH
105   $a||||||||001yy
200 1 $aEn guerre et en paix$ejournal 1940-1944$fAndrzej Bobkowski$gtrad. du polonais par Laurence Dyèvre$gtraduit du polonais par Laurence Dyèvre
210   $aMontricher$cLes Éditions Noir sur blanc$d1991
215   $a613 p.$cill.$d24 cm
300   $aTit. orig.: Szkice piórkiem
410  0$12001
454  1$12001
461  1$1001-------$12001
606 0 $aGuerra mondiale 1939-1945$xDiari e memorie
606 0 $aFrancia$xOccupazione tedesca$z1940-1945
676   $a891.853
700  1$aBOBKOWSKI,$bAndrzej$0620672
702  1$aDyèvre,$bLaurence
801  0$aIT$bsalbc$gISBD
912   $a990006059100203316
951   $aVI.4.A.5$b709 DIPSUM
959   $aBK
969   $aDSLL
979   $aMARANO$b90$c20150715$lUSA01$h1159
996   $aEn guerre et en paix$91102456
997   $aUNISA

LEADER 02531nam  22006373  450 
001 9911019238103321
005 20251116145943.0
010   $a0-470-84635-6
010   $a9786610554881
010   $a1-280-55488-6
035   $a(OCoLC)85820010
035   $a(CKB)111056485557306
035   $a(MiAaPQ)EBC4956309
035   $a(Au-PeEL)EBL4956309
035   $a(CaONFJC)MIL55488
035   $a(OCoLC)1024259038
035   $a(EXLCZ)99111056485557306
100   $a20210901d2003      uy         0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aDrug resistance in epilepsy
205   $a1st ed.
210  1$aNew York :$cWiley,$d2003.
210  4$d©2003.
215   $a1 online resource (254 pages)
225 1 $aNovartis Foundation Symposia ;$vv.Vol. 243
311 08$a0-470-84146-X 
311 08$a0-470-85189-9 
330   $aThe object of this book is to gather together workers in the fields of epilepsy, those concerned with the basic science of resistance and the blood-brain barrier, and those with clinical experience of drug resistance in cancer, with a view to stimulating further work on drug resistance in epilepsy. Whilst resistance in cancer has been extensively studied, and trials of reversal of resistance have been undertaken, with some success, resistance in epilepsy has only just begun to be addressed.
410  0$aNovartis Foundation Symposia
517   $aMechanisms of Drug Resistance in Epilepsy
517   $aDrug Resistance in Epilepsy
517   $aNovartis Foundation Symposium 243 - Mechanisms of Drug Resistance in Epilepsy - Lessons from Oncology
606   $aEpilepsy$xdrug therapy
606   $aATP Binding Cassette Transporter, Subfamily B$xmetabolism
606   $aDrug Resistance
608   $aConference Proceedings.
615 12$aEpilepsy$xdrug therapy.
615 22$aATP Binding Cassette Transporter, Subfamily B$xmetabolism.
615 22$aDrug Resistance.
676   $a616.853061
700   $aFoundation$b Novartis$01839493
701   $aBock$b Gregory$0322650
701   $aGoode$b Jamie$0283336
712 02$aNovartis Foundation.
712 12$aSymposium on Mechanisms of Drug Resistance in Epilepsy : Lessons from Oncology$f(2001 :$eLondon, England)
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9911019238103321
996   $aDrug resistance in epilepsy$94418723
997   $aUNINA